These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31704946)

  • 1. Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease.
    Benkert J; Hess S; Roy S; Beccano-Kelly D; Wiederspohn N; Duda J; Simons C; Patil K; Gaifullina A; Mannal N; Dragicevic E; Spaich D; Müller S; Nemeth J; Hollmann H; Deuter N; Mousba Y; Kubisch C; Poetschke C; Striessnig J; Pongs O; Schneider T; Wade-Martins R; Patel S; Parlato R; Frank T; Kloppenburg P; Liss B
    Nat Commun; 2019 Nov; 10(1):5094. PubMed ID: 31704946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
    Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
    Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
    Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
    Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.
    Ricke KM; Paß T; Kimoloi S; Fährmann K; Jüngst C; Schauss A; Baris OR; Aradjanski M; Trifunovic A; Eriksson Faelker TM; Bergami M; Wiesner RJ
    J Neurosci; 2020 Feb; 40(9):1975-1986. PubMed ID: 32005765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
    Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
    Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCS-1 Deficiency Affects mRNA Levels of Genes Involved in Regulation of ATP Synthesis and Mitochondrial Stress in Highly Vulnerable
    Simons C; Benkert J; Deuter N; Poetschke C; Pongs O; Schneider T; Duda J; Liss B
    Front Mol Neurosci; 2019; 12():252. PubMed ID: 31827421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Affinity of Isradipine for L-Type Ca
    Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
    J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β2-subunit alternative splicing stabilizes Cav2.3 Ca
    Siller A; Hofer NT; Tomagra G; Burkert N; Hess S; Benkert J; Gaifullina A; Spaich D; Duda J; Poetschke C; Vilusic K; Fritz EM; Schneider T; Kloppenburg P; Liss B; Carabelli V; Carbone E; Ortner NJ; Striessnig J
    Elife; 2022 Jul; 11():. PubMed ID: 35792082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
    Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
    Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
    Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
    eNeuro; 2017; 4(6):. PubMed ID: 29177188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of microglial Cav2.2 N-type voltage-dependent Ca
    Saegusa H; Li X; Wang X; Kayakiri M; Tanabe T
    FEBS Lett; 2020 Sep; 594(17):2914-2922. PubMed ID: 32484574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
    Liu YY; Zhang YN; Yang QS
    J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium currents regulate dopamine autoreceptors.
    Borgkvist A; Mosharov EV; Sulzer D
    Brain; 2014 Aug; 137(Pt 8):2113-5. PubMed ID: 25057130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CaV2.3 R-type voltage-gated Ca2+ channel in mouse sleep architecture.
    Siwek ME; Müller R; Henseler C; Broich K; Papazoglou A; Weiergräber M
    Sleep; 2014 May; 37(5):881-92. PubMed ID: 24790266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.